Rapid Therapeutic Science Laboratories Balance Sheet Health
Financial Health criteria checks 0/6
Rapid Therapeutic Science Laboratories has a total shareholder equity of $-2.7M and total debt of $3.4M, which brings its debt-to-equity ratio to -125.9%. Its total assets and total liabilities are $2.1M and $4.8M respectively.
Key information
-125.9%
Debt to equity ratio
US$3.45m
Debt
Interest coverage ratio | n/a |
Cash | US$2.16k |
Equity | -US$2.74m |
Total liabilities | US$4.81m |
Total assets | US$2.07m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: RTSL has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: RTSL has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: RTSL has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: RTSL's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Debt Coverage: RTSL's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if RTSL's interest payments on its debt are well covered by EBIT.